Value Propositions for Digital Shared Medication Plans to Boost Patient–Health Care Professional Partnerships: Co-Design Study

Coproduced SMPs can improve medication management by fostering trust and collaboration between patients and health care professionals. Successful implementation will require eHealth interoperability frameworks that embrace the complexity of medication management and support diverse use configurations. Our findings underscored the shared responsibility of all stakeholders, including policy makers and technology providers, for the effective and safe use of SMPs. The 4 value propositions offer strategic guidance, while highlighting the need for further research in different health care settings.

Authors

Institutions

Publication Details

Journal
Journal of Participatory Medicine
Published
2024-12-26
DOI
https://doi.org/10.2196/50828
Citations
3
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
1.03

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Value Propositions for Digital Shared Medication Plans to Boost Patient–Health Care Professional Partnerships: Co-Design Study

Pascal Bonnabry, Antoine Geissbühler, Christian von Plessen, Francesca Bosisio et al.
3 citations
Journal of Participatory Medicine
Pharmaceutical Practices and Patient Outcomes
1.03
article

Value Propositions for Digital Shared Medication Plans to Boost Patient–Health Care Professional Partnerships: Co-Design Study

Pascal Bonnabry, Antoine Geissbühler, Christian von Plessen, Francesca Bosisio, Alain Kaufmann, Benjamin Bugnon
article en
3 citations

Abstract

Coproduced SMPs can improve medication management by fostering trust and collaboration between patients and health care professionals. Successful implementation will require eHealth interoperability frameworks that embrace the complexity of medication management and support diverse use configurations. Our findings underscored the shared responsibility of all stakeholders, including policy makers and technology providers, for the effective and safe use of SMPs. The 4 value propositions offer strategic guidance, while highlighting the need for further research in different health care settings.

Journal of Participatory MedicineVol. 17
University of Geneva (CH), HES-SO University of Applied Sciences and Arts Western Switzerland (CH), Ono Pharmaceutical (United States) (US), University Hospital of Geneva (CH), Département de la Santé et de l'Action Sociale (CH), Adc Therapeutics (Switzerland) (CH), Centre universitaire de médecine générale et santé publique, Lausanne (CH), HES-SO Vaud (CH), University of Lausanne (CH)
Hôpitaux Universitaires de Genève
Partnerships for the goals
Openalex Percentile: Top 23%
Pharmaceutical Practices and Patient Outcomes
1.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.